|
Volumn 64, Issue 9, 2010, Pages 555-559
|
Lung cancer - Historical development, current status, future prospects;Lungenkrebs - Geschichtliche Entwicklung, derzeitiger Stand und Ausblick
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
ERLOTINIB;
GEFITINIB;
GEMCITABINE;
NAVELBINE;
PEMETREXED;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER SCREENING;
CANCER SURGERY;
DIAGNOSTIC IMAGING;
DISEASE SEVERITY;
HUMAN;
LIFE EXTENSION;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
MINIMALLY INVASIVE PROCEDURE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
REVIEW;
SPUTUM CYTODIAGNOSIS;
SURVIVAL RATE;
THORAX RADIOGRAPHY;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
GERMANY;
HISTORY, 20TH CENTURY;
HUMANS;
LUNG NEOPLASMS;
MASS SCREENING;
NEOPLASM STAGING;
PROGNOSIS;
RADIOGRAPHY, THORACIC;
SMALL CELL LUNG CARCINOMA;
SURVIVAL RATE;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 77956766258
PISSN: 09348387
EISSN: 14388790
Source Type: Journal
DOI: 10.1055/s-0030-1255636 Document Type: Review |
Times cited : (5)
|
References (10)
|